Eli Lilly Can't Escape Class Action Over Cymbalta Labeling

Law360, Los Angeles (February 26, 2013, 12:26 AM EST) -- A California judge on Monday denied a bid by Eli Lilly & Co. to escape a proposed class action alleging inadequate labeling of the antidepressant Cymbalta, saying he could not decide at this stage of the litigation whether the company properly warned doctors of the drug's risks.

U.S. District Judge Stephen V. Wilson did not rule out the possibility that the claims of four consumers, including one physician, who say they experienced “brain zaps” and other side effects when trying to stop using Cymbalta could eventually...
To view the full article, register now.



Case Information

Case Title

Jennifer L Saavedra v. Eli Lilly and Company

Case Number



California Central

Nature of Suit

Contract: Other


Stephen V. Wilson

Date Filed

October 31, 2012

Law Firms


Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.